July 24, 2014 10:38 PM ET

Pharmaceuticals

Company Overview of Constellation Pharmaceuticals, Inc.

Executive Profile

Keith E. Dionne Ph.D.

Chief Executive Officer and President, Constellation Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Keith E. Dionne, Ph.D. serves as the President and Chief Executive Officer at Constellation Pharmaceuticals, Inc. Dr. Dionne was an Entrepreneur in Residence at Third Rock Ventures, LLC. Dr. Dionne joined Third Rock Ventures on September 21, 2011. He has nearly 20 years of leadership experience in the biotechnology industry. Previously, he served as the Chief Executive Officer and President of Surface Logix, Inc. since October 2008. Dr. Dionne served as the Chief ...

Corporate Headquarters

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-714-0555
Fax: 617-661-5382

Board Members Memberships

Director

Education

MS
Massachusetts Institute of Technology
PhD
Massachusetts Institute of Technology

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Constellation Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.